Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-1_16-cv-01932/USCOURTS-caed-1_16-cv-01932-0/pdf.json

Nature of Suit Code: 367
Nature of Suit: TORTS - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability
Cause of Action: 28:1332 Diversity-Personal Injury

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

CASE NO. 1:16-CV-01932-LJO-SKO

UNITED STATES DISTRICT COURT

EASTERN DISTRICT OF CALIFORNIA

FRESNO DIVISION

GERALDINE BREAUD, INDIVIDUALLY,

Plaintiff,

v.

JANSSEN RESEARCH & DEVELOPMENT, LLC 

F/K/A JOHNSON AND JOHNSON

PHARMACEUTICAL RESEARCH AND 

DEVELOPMENT LLC; JOHNSON & JOHNSON 

COMPANY; JANSSEN ORTHO, LLC; JANSSEN 

PHARMACEUTICALS, INC. F/K/A JANSSEN 

PHARMACEUTICA INC., F/K/A ORTHOMCNEIL-JANSSEN PHARMACEUTICALS, 

INC.; BAYER CORPORATION; BAYER 

HEALTHCARE LLC; AND BAYER 

HEALTHCARE PHARMACEUTICALS INC.; 

BAYER PHARMA AG; BAYER HEALTHCARE 

AG; BAYER AG; MCKESSON CORPORATION; 

AND JOHN DOES 1-100; INCLUSIVE,

Defendants.

Case No. 1:16-cv-01932-LJO-SKO

ORDER GRANTING DEFENDANTS’

MOTION TO STAY PENDING 

TRANSFER TO MDL 2592

Date: February 9, 2017

Time: 8:30 a.m.

Judge: Hon. Lawrence J. O’Neill

Courtroom: 4

Case 1:16-cv-01932-LJO-SKO Document 9 Filed 02/03/17 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 2 - CASE NO. 1:16-CV-01932-LJO-SKO

Defendants Janssen Research & Development, LLC, Janssen Pharmaceuticals, Inc., 

Janssen Ortho LLC and Bayer HealthCare Pharmaceuticals Inc. (collectively, “Defendants”) 

Motion to Stay Pending Transfer to MDL 2592 was set for hearing on February 9, 2017. All 

parties were given notice and an opportunity to be heard by its counsel of record. Oppositions 

were due January 26, 2017. None were filed. Having reviewed all of the papers and admissible 

evidence filed in support of the motion and for good cause appearing:

IT IS HEREBY ORDERED THAT 

(1) Defendants’ Motion to Stay Pending Transfer to MDL 2592 is suitable for decision on 

the papers pursuant to Local Rule 230(g);

(2) The motion is GRANTED and this action is hereby stayed. 

(3) The hearing on the motion, set for February 9, 2017, is VACATED; and 

(4) The Parties shall notify the Court of the Judicial Panel on Multi-District Litigation’s 

decision regarding transfer and coordination within 14 days after that decision is received.

IT IS SO ORDERED.

Dated: February 3, 2017 /s/ Lawrence J. O’Neill _____ 

UNITED STATES CHIEF DISTRICT JUDGE

Case 1:16-cv-01932-LJO-SKO Document 9 Filed 02/03/17 Page 2 of 2